Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies
Crossref DOI link: https://doi.org/10.1007/s10198-016-0844-8
Published Online: 2016-11-01
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bennett, Hayley
Gordon, Jason
Jones, Beverley
Ward, Thomas
Webster, Samantha
Kalsekar, Anupama
Yuan, Yong
Brenner, Michael
McEwan, Phil
Funding for this research was provided by:
Bristol-Myers Squibb
License valid from 2016-11-01